Sale!

APP Gene Alzheimer disease type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The APP Gene Alzheimer Disease Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the APP gene, which are strongly linked to the early onset of Alzheimer’s disease. Alzheimer’s disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. The APP gene encodes the amyloid precursor protein, and mutations in this gene can lead to the abnormal accumulation of amyloid-beta peptides in the brain, a hallmark of Alzheimer’s disease.

This genetic test is particularly important for individuals with a family history of early-onset Alzheimer’s disease, as it can provide crucial information regarding their risk of developing the condition. Early detection through genetic testing allows for timely intervention and management strategies to slow the progression of the disease and improve the quality of life for affected individuals.

The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the APP Gene Alzheimer Disease Type 1 Genetic Test is 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the APP gene. The results of this test can guide healthcare professionals in developing personalized care plans for individuals at risk or affected by Alzheimer’s disease, focusing on managing symptoms and providing support for the patient and their family.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

APP Gene Alzheimer Disease Type 1 Genetic Test

At DNA Labs UAE, we offer the APP Gene Alzheimer Disease Type 1 Genetic Test at a cost of AED 4400.0. This test is designed to analyze the APP gene for mutations or variations that may increase the risk of developing Alzheimer’s disease.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the APP Gene Alzheimer Disease Type 1 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with APP Gene Alzheimer Disease Type 1.

Test Details

The APP gene is associated with Alzheimer’s disease type 1, a form of early-onset Alzheimer’s disease that typically affects individuals before the age of 65. NGS genetic testing, using next-generation sequencing technology, can be used to analyze the APP gene for mutations or variations that may increase the risk of developing Alzheimer’s disease.

This type of testing is particularly beneficial for individuals with a family history of Alzheimer’s disease or those who are concerned about their risk of developing the condition. However, it is important to note that genetic testing cannot predict with certainty whether or not an individual will develop Alzheimer’s disease, as there are many other factors that contribute to its development.

Test Name APP Gene Alzheimer disease type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for APP Gene Alzheimer disease type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with APP Gene Alzheimer disease type 1
Test Details

The APP gene is associated with Alzheimer’s disease type 1, which is a form of early-onset Alzheimer’s disease that typically affects people before the age of 65. NGS (next-generation sequencing) genetic testing can be used to analyze the APP gene for mutations or variations that may increase the risk of developing Alzheimer’s disease. This type of testing can provide valuable information for individuals who have a family history of Alzheimer’s disease or who are concerned about their risk of developing the condition. However, it is important to note that genetic testing cannot predict with certainty whether or not an individual will develop Alzheimer’s disease, as many other factors also contribute to the development of the condition.